摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-乙酰氧基吡嗪 | 98197-78-5

中文名称
2-乙酰氧基吡嗪
中文别名
——
英文名称
2-acetoxypyrazine
英文别名
acetic acid pyrazinyl ester;Essigsaeure-pyrazinylester;2-Pyrazinol, 2-acetate;pyrazin-2-yl acetate
2-乙酰氧基吡嗪化学式
CAS
98197-78-5
化学式
C6H6N2O2
mdl
——
分子量
138.126
InChiKey
WIFIJMVFIUNNMX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    228.2±20.0 °C(Predicted)
  • 密度:
    1.216±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    52.1
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    2-乙酰氧基吡嗪 作用下, 反应 0.5h, 生成 羟基吡嗪
    参考文献:
    名称:
    Oxygenation of the Unactivated Pyridine System by Acetyl Hypofluorite Made Directly from F2
    摘要:
    DOI:
    10.3987/com-88-s5
  • 作为产物:
    描述:
    吡嗪乙酰基次氟酸酯氯仿 为溶剂, 以80%的产率得到2-乙酰氧基吡嗪
    参考文献:
    名称:
    Oxygenation of the Unactivated Pyridine System by Acetyl Hypofluorite Made Directly from F2
    摘要:
    DOI:
    10.3987/com-88-s5
点击查看最新优质反应信息

文献信息

  • Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
    申请人:Omya International AG
    公开号:EP2719376A1
    公开(公告)日:2014-04-16
    An instantly floating gastroretentive drug formulation comprising at least one functionalized natural and/or synthetic calcium carbonate-comprising mineral and at least one pharmaceutically active ingredient and at least one formulating aid wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source.
    一种瞬间漂浮的胃保留药物制剂,包含至少一种功能化的天然和/或合成碳酸钙(含矿物质)、至少一种药物活性成分和至少一种配制助剂,其中所述功能化的天然或合成碳酸钙是天然或合成碳酸钙与二氧化碳和一种或多种酸的反应产物,其中二氧化碳由酸处理就地形成和/或由外部来源提供。
  • Fast disintegrating solid dosage form formulation comprising functionalized calcium carbonate and method of their manufacture
    申请人:Omya International AG
    公开号:EP2719373A1
    公开(公告)日:2014-04-16
    An orally fast disintegrating dosage forms comprising functionalized natural or synthetic calcium carbonate, at least one active ingredient and at least one disintegrant, wherein said functionalized natural or synthetic calcium carbonate is a reaction product of natural or synthetic calcium carbonate with carbon dioxide and one or more acids, wherein the carbon dioxide is formed in situ by the acid treatment and/or is supplied from an external source, and wherein the tablet dissolves in less than 20 seconds when introduced into an aqueous environment.
    一种口服快速崩解剂型,包含官能化天然或合成碳酸钙、至少一种活性成分和至少一种崩解剂,其中所述官能化天然或合成碳酸钙是天然或合成碳酸钙与二氧化碳和一种或多种酸的反应产物,其中二氧化碳由酸处理就地形成和/或由外部来源提供,片剂进入水环境后在 20 秒内溶解。
  • Filamin a binding anti-inflammatory and analgesic
    申请人:Pain Therapeutics, Inc.
    公开号:EP2918587A2
    公开(公告)日:2015-09-16
    A compound or its pharmaceutically acceptable salt, composition and method are disclosed that can provide analgesia and reduce inflammation. A contemplated compound has a structure that corresponds to Formula II, wherein the R group substituents, D, F, X, W and A are defined within.
    本发明公开了一种化合物或其药学上可接受的盐、组合物和方法,可提供镇痛和减轻炎症。一种考虑使用的化合物具有与式 II 相对应的结构,其中 R 基取代基、D、F、X、W 和 A 在式 II 中定义。
  • Dispersible dosage form
    申请人:Omya International AG
    公开号:EP3069713A1
    公开(公告)日:2016-09-21
    The present invention provides for method of improving flowability and loose bulk density of functionalized natural- and/or synthetic calcium carbonate comprising material, to the use of such improved material in ready to use granules and thereof produced dispersible dosage forms.
    本发明提供了改善官能化天然和/或合成碳酸钙材料流动性和松散堆积密度的方法,以及在即用颗粒及其生产的分散制剂中使用这种改进材料的方法。
  • DOSAGE FORM
    申请人:Omya International AG
    公开号:EP3269361A1
    公开(公告)日:2018-01-17
    The present invention relates to a dosage form comprising at least one functionalized calcium carbonate-comprising material (FCC) and at least one hot melt extruded polymer resin, a method for producing same, a pharmaceutical, nutraceutical, cosmetic, home and personal care product comprising the dosage form and the uses thereof.
    本发明涉及一种由至少一种含功能化碳酸钙的材料(FCC)和至少一种热熔挤出聚合物树脂组成的剂型,一种生产该剂型的方法,一种由该剂型组成的医药、营养保健品、化妆品、家庭和个人护理产品及其用途。
查看更多